Collectively, these data show that forodesine and dG were highly efficient at killing malignant CLL B cells with SAMHD1 mutations that cause a defect in SAMHD1 expression, while cells with intact SAMHD1 expression were spared. The gene discussed is SAMHD1; the disease is B-cell chronic lymphocytic leukemia.